A privilege escalation flaw was found in Podman. This flaw allows an attacker to publish a malicious image to a public registry. Once this image is downloaded by a potential victim, the vulnerability is triggered after a user runs the 'podman top' command. This action gives the attacker access to the host filesystem, leading to information disclosure or denial of service.
Published 2022-04-29 16:15:09
Updated 2024-06-28 16:15:03
Source Red Hat, Inc.
View at NVD,   CVE.org
Vulnerability category: Gain privilegeDenial of serviceInformation leak

Products affected by CVE-2022-1227

Threat overview for CVE-2022-1227

Top countries where our scanners detected CVE-2022-1227
Top open port discovered on systems with this issue 53
IPs affected by CVE-2022-1227 670,278
Threat actors abusing to this issue? Yes
Find out if you* are affected by CVE-2022-1227!
*Directly or indirectly through your vendors, service providers and 3rd parties. Powered by attack surface intelligence from SecurityScorecard.

Exploit prediction scoring system (EPSS) score for CVE-2022-1227

26.57%
Probability of exploitation activity in the next 30 days EPSS Score History
~ 96 %
Percentile, the proportion of vulnerabilities that are scored at or less

CVSS scores for CVE-2022-1227

Base Score Base Severity CVSS Vector Exploitability Score Impact Score Score Source First Seen
6.8
MEDIUM AV:N/AC:M/Au:N/C:P/I:P/A:P
8.6
6.4
NIST
8.8
HIGH CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
2.8
5.9
NIST

CWE ids for CVE-2022-1227

  • The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.
    Assigned by: nvd@nist.gov (Primary)
  • The product does not preserve permissions or incorrectly preserves permissions when copying, restoring, or sharing objects, which can cause them to have less restrictive permissions than intended.
    Assigned by: secalert@redhat.com (Secondary)

References for CVE-2022-1227

Jump to
This web site uses cookies for managing your session, storing preferences, website analytics and additional purposes described in our privacy policy.
By using this web site you are agreeing to CVEdetails.com terms of use!